cbdMD, Inc. (YCBD) has a negative trailing P/E of -2.6, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -37.86%.
Criteria proven by this page:
Overall SharesGrow Score: 44/100 with 1/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -54.6 | 0.00 | 504.38 | 90.23 | - |
| 2017 | -191.3 | 2.68 | 78.98 | 74.34 | 0.01% |
| 2018 | -900.4 | 11.68 | 29.43 | 808.18 | - |
| 2019 | -11.2 | 0.00 | 15.07 | 23.96 | - |
| 2020 | 56.0 | -0.51 | 8.92 | 16.86 | 0.05% |
| 2021 | -39.1 | 0.15 | 8.86 | 20.55 | 0.28% |
| 2022 | -1.5 | -0.01 | 3.42 | 3.04 | 3.72% |
| 2023 | -0.7 | 0.01 | 1.85 | 0.69 | 22.01% |
| 2024 | -4.4 | 0.05 | 8.26 | 0.83 | - |
| 2025 | -2.4 | 0.06 | 0.67 | 0.25 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-36.58 | $2.03M | $-3.36M | -165.2% |
| 2017 | $-10.44 | $4.47M | $-1.74M | -38.9% |
| 2018 | $-2.39 | $8.42M | $-412.08K | -4.9% |
| 2019 | $-114.29 | $23.65M | $-45.43M | -192.1% |
| 2020 | $12.19 | $41.88M | $12.6M | 30.1% |
| 2021 | $-19.16 | $44.48M | $-23.39M | -52.6% |
| 2022 | $-55.80 | $35.4M | $-74.09M | -209.3% |
| 2023 | $-13.32 | $24.16M | $-22.94M | -95% |
| 2024 | $-1.79 | $19.48M | $-3.7M | -19% |
| 2025 | $-1.09 | $19.19M | $-2.04M | -10.6% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-0.14 | $-0.14 – $-0.14 | $21.2M | $21.2M – $21.2M | 1 |
| 2027 | $-0.07 | $-0.07 – $-0.07 | $22.69M | $22.69M – $22.69M | 1 |
